PMGC HOLDINGS INC. Investment Income, Dividend
PMGC HOLDINGS INC. (ELAB) reported Investment Income, Dividend of $1.94 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeDividend · last filed 2026-08-14
- PMGC HOLDINGS INC. investment income, dividend for the quarter ending 2026-06-30 was $1.94K, a 35.74% decline year-over-year.
- PMGC HOLDINGS INC. investment income, dividend for the quarter ending 2026-03-31 was $2.49K.
- PMGC HOLDINGS INC. investment income, dividend for the quarter ending 2025-12-31 was $6.76K.
- PMGC HOLDINGS INC. investment income, dividend for the quarter ending 2025-09-30 was $5.78K.
- PMGC HOLDINGS INC. investment income, dividend for fiscal 2025 was $15.55K.
| Period end | Investment Income, Dividend 3 month | Investment Income, Dividend 6 month | Investment Income, Dividend 9 month | Investment Income, Dividend 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.94K 10-Q · filed 2026-08-14 | $4.43K 10-Q · filed 2026-08-14 | $11.19K derived: sum of 3 quarters · filed 2026-08-14 | $16.96K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.49K 10-Q · filed 2026-05-15 | $9.25K derived: sum of 2 quarters · filed 2026-05-15 | $15.02K derived: sum of 3 quarters · filed 2026-05-15 | $18.04K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $6.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $12.53K derived: sum of 2 quarters · filed 2026-03-30 | $15.55K derived: sum of 3 quarters · filed 2026-08-14 | $15.55K 10-K · filed 2026-03-30 |
| 2025-09-30 | $5.78K 10-Q · filed 2025-11-14 | $8.79K derived: sum of 2 quarters · filed 2026-08-14 | $8.79K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $3.02K 10-Q · filed 2026-08-14 | $3.02K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |